Neurocrine Biosciences Inc (NBIX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Finanzdaten der Neurocrine Biosciences Inc-Aktie (NBIX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	1.33% 805.50	794.90	687.50	572.60	622.10
Cost Of Revenue	25.71% 17.60	14.00	11.30	9.20	8.00
Gross Profit	0.90% 787.90	780.90	676.20	563.40	614.10
Operating Expenses	6.48% 577.00	541.90	530.60	539.80	430.30
Benefits Costs and Expenses	12.52% 566.10	503.10	528.00	557.90	431.80
Costs And Expenses	6.96% 594.60	555.90	541.90	549.00	438.30
Operating Income/Loss	11.76% 210.90	239.00	145.60	23.60	183.80
Nonoperating Income/Loss	46.02% 28.50	52.80	13.90	-8.90	6.50
Income/Loss From Continuing Operations Before Tax	17.96% 239.40	291.80	159.50	14.70	190.30
Income Tax Expense/Benefit	4.13% 85.70	82.30	52.00	6.80	60.50
Income/Loss From Continuing Operations After Tax	26.63% 153.70	209.50	107.50	7.90	129.80
Net Income/Loss	26.63% 153.70	209.50	107.50	7.90	129.80
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.80% 0.20	99.40	99.00	99.70	101.10
Diluted Average Shares	99.51% 0.50	102.50	101.00	102.50	104.30
Basic Earnings Per Share	27.01% 1.54	2.11	1.09	0.08	1.28
Diluted Earnings Per Share	27.45% 1.48	2.04	1.06	0.08	1.24
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RDY

$14.13

1.53%

RGC

$23.23

3.21%

ELAN

$22.94

1.15%

VTRS

$13.51

2.10%

UTHR

$536.12

0.62%